aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, Jinlin Hou, Ramazan Idılman et al.|Journal of Hepatology|2020Cited by 346
New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatmentYameng Sun, Jidong Jia, Jialing Zhou et al.|Hepatology|2016Cited by 156
Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 CountriesJin-Lin Hou, Seng Gee Lim, Wei Zhao et al.|Clinical Gastroenterology and Hepatology|2019Cited by 111
Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy IndividualsFateh Bazerbachi, Kymberly D. Watt, Samir Haffar et al.|Clinical Gastroenterology and Hepatology|2018Cited by 80
Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label studyXiaoning Wu, Hong You, Yiwen Shi et al.|Expert Opinion on Biological Therapy|2018Cited by 44